| 571 |
SERUM CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME |
2009 |
| 572 |
The accurate prediction of rare hemoglobin variants
using a combination of high performance liquid
chromatography, retention time and isoelectric focusing
electrophoresis position |
2009 |
| 573 |
The Association of PvuII Lipoprotein Lipase Gene Polymorphism with Coronary Artery Disease in Egyptians |
2009 |
| 574 |
The Association of PvuII Lipoprotein Lipase Gene Polymorphism with Coronary Artery Disease in Egyptians |
2009 |
| 575 |
The Association of PvuII Lipoprotein Lipase Gene Polymorphism with Coronary Artery Disease in Egyptians |
2009 |
| 576 |
The Association of PvuII Lipoprotein Lipase Gene Polymorphism with Coronary Artery Disease in Egyptians |
2009 |
| 577 |
The Association of PvuII Lipoprotein Lipase Gene Polymorphism with Coronary Artery Disease in Egyptians |
2009 |
| 578 |
THE ROLE OF ANTINUCLEAR ANTIBODIES TOGETHER WITH SOME OTHER SEROLOGICAL PARAMETERS AS BIOMARKERS OF CARDIOVASCULAR MORBIDITY IN PATIENTS WITH END STAGE RENAL DISEASE.CASE CONTROL STUDY |
2009 |
| 579 |
•Relationship of Serum Resistin and Adiponectin to Insulin Resistance in Cirrhotic Patients |
2009 |
| 580 |
12.FACTOR V LEIDEN IN PATIENTS WITH PORTAL VEIN THROMBOSIS. |
2008 |
Do you have any questions? 
